Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform

Go back to Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform
(NASDAQ: LFWD) Delayed: 6.90 -0.24 (3.36%)
Previous Close $7.14    52 Week High
Open $7.11    52 Week Low
Day High $7.11    P/E N/A 
Day Low $6.90    EPS
Volume 2,000